Get the Stockscreener App
361.64
0.92%
-3.36
After Hours:
361.64
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Cencora Inc stock is traded at $361.64, with a volume of 2.05M.
It is down -0.92% in the last 24 hours and up +11.38% over the past month.
Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health hold over 90% share of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.
See More
Previous Close:
$365.00
Open:
$366.64
24h Volume:
2.05M
Relative Volume:
1.42
Market Cap:
$75.59B
Revenue:
$321.33B
Net Income/Loss:
$1.57B
P/E Ratio:
45.48
EPS:
7.9518
Net Cash Flow:
$3.21B
1W Performance:
-0.94%
1M Performance:
+11.38%
6M Performance:
+24.61%
1Y Performance:
+48.90%
1-Day Range:
$360.54
$366.87
1-Week Range:
$360.14
$369.00
52-Week Range:
$223.92
$369.00
Cencora Inc Stock (COR) Company Profile
Name
Cencora Inc
Sector
Industry
Phone
610-727-7000
Address
1 WEST FIRST AVENUE, CONSHOHOCKEN
Compare COR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
COR
Cencora Inc
|
361.64 | 70.77B | 321.33B | 1.57B | 3.21B | 7.9518 |
|
MCK
Mckesson Corporation
|
860.75 | 105.56B | 387.09B | 4.23B | 6.01B | 32.12 |
|
CAH
Cardinal Health Inc
|
206.97 | 48.99B | 234.31B | 1.61B | 4.45B | 6.6243 |
|
HSIC
Henry Schein Inc
|
71.20 | 8.39B | 12.50B | 314.00M | 421.00M | 2.44 |
|
AHG
Akso Health Group Adr
|
1.5667 | 752.41M | 2.22M | -5.63M | -1.68M | -0.24 |
Cencora Inc Stock (COR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-03-25 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Dec-04-24 | Resumed | Mizuho | Outperform |
| Sep-18-24 | Downgrade | BofA Securities | Buy → Neutral |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Dec-14-23 | Initiated | Wells Fargo | Equal Weight |
| Mar-31-23 | Initiated | Citigroup | Buy |
| Jan-31-23 | Resumed | Evercore ISI | Outperform |
| Oct-11-22 | Upgrade | BofA Securities | Neutral → Buy |
| Aug-22-22 | Resumed | Morgan Stanley | Equal-Weight |
| Jul-11-22 | Downgrade | Evercore ISI | Outperform → In-line |
| Jun-07-22 | Upgrade | Deutsche Bank | Hold → Buy |
| May-26-22 | Upgrade | Barclays | Equal Weight → Overweight |
| Apr-12-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Apr-01-22 | Resumed | Credit Suisse | Outperform |
| Mar-12-21 | Resumed | Evercore ISI | In-line |
| Feb-04-21 | Upgrade | Evercore ISI | In-line → Outperform |
| Feb-02-21 | Upgrade | Cowen | Market Perform → Outperform |
| Jan-06-21 | Upgrade | BofA Securities | Underperform → Neutral |
| Jan-06-21 | Upgrade | Credit Suisse | Neutral → Outperform |
| Dec-10-20 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| Dec-03-20 | Initiated | Mizuho | Neutral |
| Aug-06-20 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jul-15-20 | Initiated | Barclays | Underweight |
| Jun-15-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Apr-23-20 | Resumed | Credit Suisse | Outperform |
| Apr-16-20 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Apr-13-20 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Apr-01-20 | Upgrade | JP Morgan | Neutral → Overweight |
| Mar-17-20 | Upgrade | Citigroup | Neutral → Buy |
| Feb-11-20 | Downgrade | BofA/Merrill | Buy → Underperform |
| Feb-07-20 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Sep-12-19 | Initiated | Deutsche Bank | Hold |
| Jul-10-19 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Apr-11-19 | Initiated | Guggenheim | Buy |
| Apr-10-19 | Downgrade | BofA/Merrill | Buy → Underperform |
| Apr-10-19 | Downgrade | Evercore ISI | Outperform → In-line |
| Feb-11-19 | Downgrade | JP Morgan | Neutral → Underweight |
| Jan-17-19 | Initiated | UBS | Buy |
| Dec-10-18 | Downgrade | Jefferies | Buy → Hold |
| Oct-26-18 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Sep-20-18 | Initiated | Berenberg | Buy |
| Jul-17-18 | Resumed | Stifel | Hold |
| Apr-09-18 | Initiated | MoffettNathanson | Buy |
| Mar-12-18 | Upgrade | KeyBanc Capital Mkts | Sector Weight → Overweight |
| Mar-12-18 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Sep-25-17 | Initiated | JP Morgan | Neutral |
| Sep-22-17 | Initiated | William Blair | Outperform |
View All
Cencora Inc Stock (COR) Latest News
How Cencora Inc. (ABG) stock compares with tech leadersJuly 2025 Trends & AI Driven Price Forecasts - newser.com
Will Cencora Inc. stock sustain bullish trend into 20252025 AllTime Highs & Daily Profit Focused Screening - newser.com
Can Cencora Inc. stock double in coming yearsGap Down & Daily Risk Controlled Trade Plans - newser.com
Is Cencora Inc. stock a top dividend aristocrat candidatePortfolio Value Report & Safe Swing Trade Setups - newser.com
Will Cencora Inc. stock gain from lower inflationPortfolio Return Report & AI Powered Trade Plan Recommendations - newser.com
What sentiment indicators say about Cencora Inc. stockJuly 2025 Rallies & Fast Exit and Entry Strategy Plans - newser.com
Can Cencora Inc. stock beat analyst upgradesJuly 2025 Action & AI Enhanced Trading Signals - newser.com
Will Cencora Inc. (ABG) stock attract long term capital inflows2025 Market Overview & Daily Oversold Bounce Ideas - newser.com
How Cencora Inc. stock moves on employment dataJuly 2025 Volume & Fast Gain Swing Trade Alerts - newser.com
How Cencora Inc. (ABG) stock reacts to weak economyWeekly Trend Recap & Accurate Technical Buy Alerts - newser.com
Can Cencora Inc. stock surprise markets with earningsJuly 2025 Levels & Daily Oversold Bounce Ideas - newser.com
Can Cencora Inc. (ABG) stock sustain free cash flow2025 Macro Impact & Reliable Volume Spike Trade Alerts - newser.com
Why Cencora Inc. stock could be top winnerWeekly Risk Report & AI Powered Buy and Sell Recommendations - newser.com
Cencora Stock: Is COR Outperforming the Health Care Sector? - MSN
Cencora’s Earnings Surprise? Pharma Distributor Posts Big Gains—and a Rare Quarterly Loss - MSN
Is Cencora Inc. (ABG) stock a buy during volatile markets2025 Year in Review & Technical Confirmation Trade Alerts - newser.com
Cencora (COR) Price Target Increased by 12.54% to 388.50 - Nasdaq
How Cencora Inc. (ABG) stock trades after rate cutsMarket Activity Report & Real-Time Stock Price Movement Reports - newser.com
Is Cencora Inc. showing signs of accumulationPortfolio Risk Report & Weekly Chart Analysis and Trade Guides - newser.com
What makes Cencora Inc. stock attractive to growth fundsJuly 2025 Reactions & Safe Capital Preservation Plans - newser.com
Will Cencora Inc. stock see insider buyingJuly 2025 Setups & Free Weekly Chart Analysis and Trade Guides - newser.com
Cencora's Nationwide Automation Push and Dividend Hike Could Be a Game Changer for COR - simplywall.st
Cencora Inc. stock outlook for YEARMarket Trend Summary & Risk Managed Trade Strategies - newser.com
Live market analysis of Cencora Inc.Recession Risk & Real-Time Stock Price Movement Reports - newser.com
Cencora Inc Stock (COR) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.38%
0.07%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):